June 8, 2026

Insurance Denied Your Sleep Study? Here's Exactly What to Do

Your doctor suspected sleep apnea or another sleep disorder and ordered a sleep study. Your insurance company said no, or approved a home test when your doctor specifically ordered an in-lab polysomnogram, or denied the CPAP titration study that's supposed to follow the diagnostic study. Sleep study denials are some of the most common prior authorization denials in 2026, and the rules around what insurers must cover are actually fairly well established.

Sleep apnea is dramatically underdiagnosed (estimates suggest 80% of moderate-to-severe cases are undiagnosed) and untreated sleep apnea is linked to cardiovascular disease, stroke, type 2 diabetes, and motor vehicle accidents from daytime sleepiness. The clinical case for sleep studies is strong, and the American Academy of Sleep Medicine (AASM) publishes detailed criteria that insurers reference. Knowing those criteria is the foundation of a successful appeal.

Why Insurers Deny Sleep Studies

Sleep study denials typically fall into one of these patterns. Each has a specific counter-argument:

Medical necessity not established

The most common denial reason. The insurer (or their utilization management vendor, often eviCore or Carelon) concluded the clinical documentation doesn't justify a sleep study. Often this reflects insufficient documentation of symptoms or risk factors rather than an actually inappropriate test.

Home sleep test required instead of in-lab

Insurers heavily prefer home sleep apnea tests (HSAT) because they cost dramatically less than in-lab polysomnography (PSG). Many denials approve the home test but reject the in-lab study. The AASM has specific criteria for when in-lab PSG is required vs. when home testing is appropriate. If your case meets the in-lab criteria, you have a strong appeal.

BMI or symptoms threshold not met

Some insurers apply BMI thresholds (often BMI greater than 30) or require specific symptom combinations before approving sleep studies. The clinical reality is broader: lean patients can have significant sleep apnea, and symptoms beyond classic loud snoring (witnessed apneas, morning headaches, treatment-resistant hypertension, atrial fibrillation, nocturia) all warrant evaluation.

Prior CPAP trial required

In some cases insurers require a documented trial of a CPAP machine before approving a formal titration study. This puts the cart before the horse clinically (you typically need the diagnostic study to determine appropriate pressure settings) and is appealable.

Prior authorization not obtained

Sleep studies almost always require prior authorization in 2026. If your doctor's office didn't submit the prior auth, the study may be denied even though it was clinically appropriate.

The In-Lab vs. Home Test Fight

This is the most common sleep study denial pattern and deserves its own treatment. The AASM clinical practice guideline (most recently updated in 2017) specifies that in-lab polysomnography is recommended over home sleep apnea testing in these situations:

• Significant cardiopulmonary disease (CHF, COPD requiring oxygen, recent MI or stroke)
• Potential respiratory muscle weakness due to neuromuscular conditions
• Awake hypoventilation or suspicion of sleep-related hypoventilation
• Chronic opioid medication use
• History of stroke or severe insomnia
• Suspected central sleep apnea (not just obstructive)
• Suspected sleep disorders other than sleep apnea (narcolepsy, parasomnias, periodic limb movement disorder)
• Patient is unable to use the home study device correctly (severe arthritis, dementia, etc.)

If any of these apply to your situation, the AASM guidelines support in-lab PSG over home testing. Your appeal should cite the specific 2017 AASM clinical practice guideline (Kapur et al., Journal of Clinical Sleep Medicine, 2017) and explain which criterion applies to your case.

How to Argue Medical Necessity

The strongest sleep study appeals combine validated screening tools with specific clinical indicators. Here's how to build that argument:

Use validated screening tools

Two scoring tools are widely used and accepted by insurers:

• STOP-BANG questionnaire: 8 yes/no questions assessing snoring, tiredness, observed apneas, blood pressure, BMI, age, neck circumference, and gender. Scores of 3+ indicate intermediate risk; 5+ indicate high risk of moderate-to-severe sleep apnea.
• Epworth Sleepiness Scale (ESS): 8-item self-report measure of daytime sleepiness. Scores of 10+ indicate excessive daytime sleepiness; 16+ indicates severe sleepiness warranting urgent evaluation.

If you've scored 5+ on STOP-BANG or 10+ on Epworth, include the score in your appeal. These are the same tools insurers use internally to triage requests.

Document specific clinical indicators

Beyond the screening tools, list specific clinical findings that support the study: witnessed apneas (especially by a bed partner), morning headaches, treatment-resistant hypertension, atrial fibrillation, nocturia, refractory depression, severe fatigue interfering with work. Each finding is independently supportive.

Address comorbidities

Sleep apnea is associated with significant comorbidities. If you have hypertension, type 2 diabetes, atrial fibrillation, heart failure, prior stroke, or are a commercial driver (DOT-regulated), your appeal should emphasize the clinical urgency of diagnosis. The cardiovascular risk profile shifts the medical necessity calculus.

For in-lab denials, identify the specific AASM criterion

Don't just argue "I need in-lab." Identify which of the AASM criteria above applies to your case and cite it specifically. For example: "Per the 2017 AASM clinical practice guideline, in-lab polysomnography is recommended over home sleep apnea testing in patients with significant cardiopulmonary disease. The patient has documented congestive heart failure (NYHA Class II) and is therefore an in-lab candidate per AASM criteria."

How to Get Your Doctor Involved

Your sleep medicine specialist (or your primary care physician if you don't have a sleep medicine referral yet) is your most important ally. A letter of medical necessity from your doctor often resolves the denial without further escalation.

Ask your doctor for a letter that includes:

• Your clinical history, sleep symptoms, and physical exam findings
• Your STOP-BANG and Epworth scores
• Relevant comorbidities (cardiovascular, metabolic, neurological)
• For in-lab denials: the specific AASM 2017 criterion that applies to your case
• The specific suspected diagnosis (obstructive sleep apnea, central sleep apnea, narcolepsy, etc.)
• The clinical consequences of delayed diagnosis (untreated cardiovascular risk, driver safety, etc.)

Request a peer-to-peer reviewwith the insurer's medical reviewer. For sleep studies, peer-to-peer reviews are often successful because the criteria are well-defined and a sleep specialist talking to a generalist reviewer usually clarifies the clinical picture quickly.

The Appeal Process for Sleep Study Denials

The process follows standard health insurance appeal structure:

1. File your internal appealwithin the deadline on your denial letter (typically 180 days). Include your doctor's letter, STOP-BANG/Epworth scores, AASM guideline citation, and relevant comorbidity documentation.
2. Request a peer-to-peer review in parallel with the written appeal, especially for in-lab denials where the AASM criteria are specific and well-documented.
3. Follow up on response deadlines. Most state laws require insurers to respond within 30 days for pre-service requests.
4. File a state DOI complaint if the appeal is denied or ignored. Sleep apnea is a recognized chronic disease and state insurance commissioners have authority over coverage disputes.
5. Request external reviewas the final step. An independent medical reviewer evaluates whether the sleep study meets clinical criteria. The reviewer's decision is binding on the insurer.

Don't Wait on a Diagnosis

Untreated sleep apnea is not a minor problem. The cardiovascular consequences (hypertension, atrial fibrillation, stroke risk) accumulate quietly over years, and the daytime consequences (cognitive impairment, motor vehicle accident risk, depression) impact daily life. Insurance denial isn't a medical opinion; it's a cost decision dressed up as one.

If the appeal process feels overwhelming, DenyBackgenerates a complete appeal package tailored to sleep study denials, including AASM clinical guideline citations, validated screening tool references (STOP-BANG, Epworth), and your state's specific insurance regulations. The appeal is physically mailed to your insurer via certified mail, then automatically escalated through follow-up letters, a state Department of Insurance complaint, and an external review request over 45 days. The whole package costs $39.

Whether you appeal yourself or use a service, don't accept the denial and wait. The clinical case for sleep studies is one of the better-established ones in insurance medicine. Fight for the diagnostic workup your doctor ordered.